OC
THQ

Oppenheimer & Co’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Oppenheimer & Co’s Portfolio THQ Stock Details THQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Sell
24,944
-490
-2% -$8.94K 0.01% 1285
2026
Q1 		$427K Sell
25,434
-3,093
-11% -$58.2K 0.01% 1251
2025
Q4 		$546K Buy
28,527
+97
+0.3% +$1.78K 0.01% 1042
2025
Q3 		$492K Sell
28,430
-89
-0.3% -$1.52K 0.01% 1177
2025
Q2 		$524K Sell
28,519
-1,083
-4% -$20.1K 0.01% 1126
2025
Q1 		$611K Sell
29,602
-4,911
-14% -$100K 0.01% 1012
2024
Q4 		$651K Buy
34,513
+159
+0.5% +$3.29K 0.01% 971
2024
Q3 		$759K Sell
34,354
-2,160
-6% -$46.2K 0.01% 888
2024
Q2 		$744K Sell
36,514
-1,524
-4% -$30.3K 0.01% 868
2024
Q1 		$765K Sell
38,038
-6,694
-15% -$129K 0.01% 844
2023
Q4 		$810K Buy
44,732
+9,885
+28% +$167K 0.01% 784
2023
Q3 		$592K Sell
34,847
-3,561
-9% -$66.2K 0.01% 877
2023
Q2 		$732K Buy
38,408
+18,469
+93% +$348K 0.01% 829
2023
Q1 		$374K Buy
19,939
+62
+0.3% +$1.19K 0.01% 1057
2022
Q4 		$394K Buy
19,877
+2,560
+15% +$50.5K 0.01% 990
2022
Q3 		$314K Buy
17,317
+938
+6% +$18.8K 0.01% 1049
2022
Q2 		$327K Sell
16,379
-592
-3% -$12.4K 0.01% 1074
2022
Q1 		$378K Sell
16,971
-514
-3% -$11.5K 0.01% 1101
2021
Q4 		$449K Sell
17,485
-126
-0.7% -$3.03K 0.01% 1086
2021
Q3 		$399K Buy
17,611
+587
+3% +$14.1K 0.01% 1108
2021
Q2 		$393K Buy
17,024
+1,039
+6% +$23.9K 0.01% 1127
2021
Q1 		$347K Buy
15,985
+1,625
+11% +$34.1K 0.01% 1111
2020
Q4 		$293K Buy
14,360
+3,511
+32% +$67.1K 0.01% 1096
2020
Q3 		$196K Buy
10,849
+12
+0.1% +$218 ﹤0.01% 1165
2020
Q2 		$193K Buy
+10,837
New +$191K 0.01% 1130

Other funds holding THQ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.1B AUM 11.31% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Oppenheimer & Co's THQ Position: Q2 2026 in Review

Oppenheimer & Co reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 1.9% in Q2 2026, selling an estimated $8.94K and leaving 24,944 shares worth $467K. The position accounts for 0.01% of the portfolio, ranked #1285.

Oppenheimer & Co first reported a position in THQ in Q2 2020 and has held it in 25 quarters since. The position peaked at $810K in Q4 2023. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • Oppenheimer & Co held 24,944 shares of abrdn Healthcare Opportunities Fund worth $467K as of Q2 2026.
  • Oppenheimer & Co sold 490 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $8.94K.
  • abrdn Healthcare Opportunities Fund made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1285 holding.
  • Oppenheimer & Co first reported a position in abrdn Healthcare Opportunities Fund in Q2 2020 and has held it in 25 quarters since.
  • Oppenheimer & Co's abrdn Healthcare Opportunities Fund position peaked at $810K in Q4 2023.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.